Related Experiment Video
Updated: Aug 13, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Serum creatine phosphokinase monitoring in patients infected with HIV
Tonio V Piscopo1, Paul S McDonald, Alastair R O Miller
1Worcestershire HIV Clinic, Worcestershire Acute Hospitals NHS Trust, Worcestershire Royal Hospital, Charles Hastings Way, Worcester WR5 1DD, UK. tpiscopo@maltanet.net
Insights
Routine creatine phosphokinase (CPK) monitoring in HIV patients without muscle disease symptoms is not supported by this study. Elevated CPK levels were rarely associated with clinical features of muscle disease (CFMD) or changes in patient management.
Area of Science:
- Clinical Medicine
- Biochemistry
- Infectious Diseases
Background:
- Routine creatine phosphokinase (CPK) monitoring is performed in some human immunodeficiency virus (HIV) clinics, regardless of patient symptoms.
- The clinical significance of elevated CPK levels in asymptomatic HIV patients remains unclear.
Purpose of the Study:
- To determine if routine serum CPK elevations in HIV patients are associated with clinical features of muscle disease (CFMD).
- To assess whether CPK elevations influence patient management in HIV clinics.
Main Methods:
- Retrospective study of patients attending the Worcestershire HIV clinic from 1987 to 2001.
- Analysis of serum CPK levels in relation to the presence or absence of CFMD.
- Evaluation of changes in patient management following CPK level monitoring.
Main Results:
- No association was found between CFMD and a general rise in CPK levels.
- Major CPK elevations (>400 IU/L) were significantly associated with CFMD.
- No patient without CFMD exhibited a persistent CPK rise (>200 IU/L); management rarely changed due to enzyme elevations.
Conclusions:
- Routine CPK monitoring in asymptomatic HIV patients is not supported by this study's findings.
- The likelihood of detecting a significant and persistent CPK rise in HIV patients without CFMD is low.
- CPK monitoring should be considered in the context of specific clinical indications rather than routine practice.
Abstract:
Creatine phosphokinase (CPK) estimations are done routinely in some HIV clinics, irrespective of patient symptoms. We studied patients attending the Worcestershire HIV clinic between 1987 and 2001 to identify whether routine elevations in serum levels of CPK in patients with HIV were associated with clinical features of muscle disease (CFMD), and whether such elevations influenced patient management. There was no association between CFMD and a rise in CPK. Major rises of CPK >400 IU/L were significantly associated with CFMD. No individual had a persistent CPK rise >200 IU/L without CFMD. In the great majority of cases, there was no change in management consequent to enzyme rises. In patients with HIV infection and no CFMD, the chance of finding a major and persistent CPK rise is low. This study does not support the practice of routine monitoring of CPK in asymptomatic patients attending HIV clinics.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Cryptococcal Meningitis

